Anti-CD20 therapies for pediatric-onset multiple sclerosis: A systematic review.
Masoud EtemadifarHosein NouriNahad SedaghatAryana RamezaniParisa K KargaranMehri SalariHasan Kaveyee
Published in: Multiple sclerosis and related disorders (2024)
Although anti-CD20 therapy is associated with some AEs, it can be provided in several circumstances, especially to patients with highly active disease, or ones resistant to platform therapies.